Compounds > suberoyl bis-hydroxamic acid
Page last updated: 2024-11-04

suberoyl bis-hydroxamic acid and Squamous Cell Carcinoma of Head and Neck

suberoyl bis-hydroxamic acid has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chikamatsu, K1
Ishii, H1
Murata, T1
Sakakura, K1
Shino, M1
Toyoda, M1
Takahashi, K1
Masuyama, K1

Other Studies

1 other study available for suberoyl bis-hydroxamic acid and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck.
    Cancer science, 2013, Volume: 104, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Bindi

2013